Economic Evaluation of Dialysis Dependence Following Renal Replacement Therapy for Critically ILL Acute Kidney Injury Patients

Ariza, J.G.; Barrera, Lizeth Katherine; Sanabria, Mauricio; Echeverri, José Miguel Abad; Huérfano, Manuel; Arboleda, Alejandra Cañas; Bunch, Alfonso; García, J.M. Olivera; Vesga, Jasmín; Larrarte, Carolina

doi:10.1016/j.jval.2017.08.2535

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Audit results in the renal recovery have motivated the development of an analytical model of Markov that adapts a previously validated model to our reality, in a time horizon of 5-10 years and subsequent simulation of a hypothetical cohort of 1000 patients. Health costs (COP) and adjusted life quality (QALY) were compared between intermittent hemodialysis and CRRT provided by a renal emergency team ( Table 9) [54]. Continuous Renal Replacement Therapy Specialized Teams: A Challenge to Improve Quality Performance http://dx.doi.org/10.5772/intechopen.79853…”

Section: Economic Analysis Of the Auditmentioning

confidence: 99%

Continuous Renal Replacement Therapy Specialized Teams: A Challenge to Improve Quality Performance

Echeverri¹,

Larrarte²,

Huérfano³

2019

Aspects in Continuous Renal Replacement Therapy

View full text Add to dashboard Cite

Acute kidney injury is a common condition in critical care, and continuous extracorporeal therapies have become part of the requirement for multiorgan support in critically ill patients. Availability of continuous renal replacement therapy (CRRT) in a healthcare center can influence the therapy performance and patient's results, and it is challenging to attain high-quality standards in centers without previous experience in CRRT and with new therapy users. This chapter describes the experience of a highly specialized acute renal care service model with emphasis on timely interventions by an exclusive CRRT team, education and training, protocol development, quality performance improvement, and its impact on optimal clinical and pharmacoeconomic outcomes.

show abstract

Section: Economic Analysis Of the Auditmentioning

confidence: 99%

Continuous Renal Replacement Therapy Specialized Teams: A Challenge to Improve Quality Performance

Echeverri¹,

Larrarte²,

Huérfano³

2019

Aspects in Continuous Renal Replacement Therapy

View full text Add to dashboard Cite

show abstract

A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury

Singh

Hussain

Kher

et al. 2021

Expert Review of Pharmacoeconomics & Outcomes Research

View full text Add to dashboard Cite

Evaluating a remote patient monitoring program for automated peritoneal dialysis

et al. 2020

View full text Add to dashboard Cite

Background: The benefits of automated peritoneal dialysis (APD) have been established, but patient adherence to treatment remains a concern. Remote patient monitoring (RPM) programs are a potential solution; however, the cost implications are not well established. This study modeled, from the payer perspective, expected net costs and clinical consequences of a novel RPM program in Colombia. Methods: Amarkov model was used to project costs and clinical outcomes for APD patients with and without RPM. Clinical inputs were directly estimated from Renal Care Services data or taken from the literature. Dialysis costs were estimated from national fees. Inpatient costs were obtained from a recent Colombian study. The model projected overall direct costs and several clinical outcomes. Deterministic and probabilistic sensitivity analyses (DSA and PSA) were also conducted to characterize uncertainty in the results. Results: The model projected that the implementation of an RPM program costing US$35 per month in a cohort of 100 APD patients over 1 year would save US$121,233. The model also projected 31 additional months free of complications, 27 fewer hospitalizations, 518 fewer hospitalization days, and 6 fewer peritonitis episodes. In the DSA, results were most sensitive to hospitalization rates and days of hospitalization, but cost savings were robust. The PSA found there was a 91% chance for the RPM program to be cost saving. Conclusion: The results of the model suggest that RPM is cost-effective in APD patients which should be verified by a rigorous prospective cost analysis.

show abstract

Economic Evaluation of Dialysis Dependence Following Renal Replacement Therapy for Critically ILL Acute Kidney Injury Patients

Cited by 3 publications

References 0 publications

Continuous Renal Replacement Therapy Specialized Teams: A Challenge to Improve Quality Performance

Continuous Renal Replacement Therapy Specialized Teams: A Challenge to Improve Quality Performance

A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury

Evaluating a remote patient monitoring program for automated peritoneal dialysis

Contact Info

Product

Resources

About